• Users Online:2096
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2014  |  Volume : 8  |  Issue : 4  |  Page : 218-223

Azadirachta indica in treatment of acne vulgaris-an open-label observational study


1 Senior Medical Officer, Directorate of AYUSH, Government of NCT of Delhi, New Delhi, India
2 Director General, Central Council for Research in Homoeopathy, New Delhi, India

Correspondence Address:
Dr. Anjali Miglani
C-1/31, Himalayan Residency, Plot 10, Sector 22, Dwarka, New Delhi - 110 077
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-7168.147321

Clinical trial registration Clinical Trials.gov Identifier: NCT01321645

Rights and Permissions

Introduction: Azadirachta Indica (Aza.) has been used since decades in traditional medicine for the treatment of acne; even in Homoeopathy, it is recommended but its precise indications are still elusive. This study was undertaken to determine the usefulness of Azadirachta indica in the treatment of acne vulgaris and find its indications. Materials and Methods: A prospective, non-randomized, open-label interventional study was conducted after approval from ethical committee. Azadirachta indica was prescribed in raising potencies from 6C up to 1M. The observational period was of 6 months. Outcome measures were Lesion counts, Global Acne Grading System (GAGS) score and Acne-specific Quality of Life questionnaire (Acne-QoL) score. Data was analyzed using paired t-test, Wilcoxon signed rank tests and Pearson's correlation tests. Results: Out of 31 enrolled participants, 29 completed the 6-months follow-up. Two subjects did not report after 2-3 months but were included under Intention-To-Treat (ITT). Though there were overall statistically significant results in respect of Lesion counts, GAGS and Acne QoL score (P < 0.001) but no effect was seen in inflammatory lesions. Conclusions: Azadirachta indica has a role in early and recovery phase of acne when inflammatory changes are least. Further study on a larger sample size is desirable. Trial is registered at Clinical Trials.gov Identifier: NCT01321645.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3986    
    Printed64    
    Emailed0    
    PDF Downloaded633    
    Comments [Add]    

Recommend this journal